Thomas Rückle
Thomas Rückle publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as PI3K/AKT/mTOR signaling in cancer, Chemical Synthesis and Analysis and Biochemical and Molecular Research.
- World rank
- #321,096 of 7,710,434 ranked researchers
- Rank in Switzerland
- #6,097 of 80,918
- Works
- 68
- Citations
- 4.9k
- Citations per work
- 71.8
What does Thomas Rückle research?
Thomas Rückle's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Medicine (16%), Immunology and Microbiology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences3347.8%
- Everything else2130.9%
- Health Sciences1116.3%
- Medicine1116.3%
- Physical Sciences35.0%
- Chemistry35.0%
- 1Molecular Biology35% of their works
- 2Immunology13% of their works
- 3Oncology8% of their works
- 4Organic Chemistry5% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Genetics4% of their works
Research topics
Which keywords describe Thomas Rückle's research?
The keywords of their largest research topics: mTOR, Signaling, Drug Discovery, Peptide Synthesis, Enzyme Regulation, Nucleotide Metabolism, Artemisinin Resistance and Plasmodium falciparum.
- Toll-like Receptors
- Sortase
- Genomic Aberrations
- Cyclotides
- Plasmodium falciparum
- Nucleotide Metabolism
- Peptide Synthesis
- mTOR
- Signaling
- Drug Discovery
- Enzyme Regulation
- Artemisinin Resistance
- Chronic Lymphocytic Leukemia
- Foxp3
- Pattern Recognition Receptors
- TGF-ß
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 16 words, with their numbers
- Signaling131 topic
- mTOR131 topic
- Drug Discovery91 topic
- Peptide Synthesis91 topic
- Enzyme Regulation71 topic
- Nucleotide Metabolism71 topic
- Artemisinin Resistance61 topic
- Plasmodium falciparum61 topic
- Chronic Lymphocytic Leukemia51 topic
- Cyclotides51 topic
- Foxp351 topic
- Genomic Aberrations51 topic
- Pattern Recognition Receptors51 topic
- Sortase51 topic
- TGF-ß51 topic
- Toll-like Receptors51 topic
Where does Thomas Rückle work?
Thomas Rückle's main affiliation in the publication record is Merck Serono S.A. (Switzerland), Switzerland.
How many publications and citations does Thomas Rückle have?
OpenAlex counts 68 works and 4,882 citations for Thomas Rückle, an h-index of 36, ranking #321,096 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Thomas Rückle. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.